Roche has launched its uPath enterprise software for digital pathology, billing it as an improvement in speed and performance compared to its previous version known as Ventana Virtuoso. According to ...

- Innovative design integrates powerful imaging and analysis tools for more efficient workflow - Personalized workflow software allows pathologists to move seamlessly between a variety of stains in a ...

Roche announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with ...

Roche announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best ...

uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis aid pathologists in providing faster, more accurate patient diagnoses in breast cancer In combination with the VENTANA DP 200 slide ...

PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche. The strategic partnership will allow PathAI to develop and distribute its AI ...

Roche has launched a new version of its digital pathology platform in Europe, with a CE-IVD mark for an artificial-intelligence-powered image analysis algorithm aimed at non-small cell lung cancer.

TUCSON, Ariz., Jan. 15, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new standard ...